CD4 and cancer: In the two female patients with malignancies, the absolute counts of CD4+ T helper cells were statistically significantly lower than in the CVID without malignancy group (p = 0.044), and the numbers of T CD4+ naive cells and RTE were in the malignancy group lower but not statistically significantly.